ライフサイエンスコーパス: corticotrophin

1 nhibitory effects of GCs on the secretion of corticotrophin (ACTH), and used molecular, genetic, and

2 hromosome 12p13 region were present in human corticotrophin (ACTH)-secreting pituitary tumours.

3 After an overnight fast, basal corticotrophin and corticosteroid levels are elevated, a

4 ibitum exhibited increased basal but reduced corticotrophin and corticosterone responses to restraint

5 es of the paraventricular nucleus to release corticotrophin releasing factor (CRF) into the hypothala

6 The neuropeptide corticotrophin releasing factor (CRF) is released during

7 (CART), glucagon-like peptide-1 (GLP-1) and corticotrophin releasing factor (CRF) might be mediated

8 memory formation, potentially by activating corticotrophin releasing factor (CRF) neurons in the ant

9 es have demonstrated that antagonists of the corticotrophin releasing factor (CRF) receptor markedly

10 inputs originating from the LH and PAG, and corticotrophin releasing factor (CRF) selectively inhibi

11 We investigated how corticotrophin releasing factor (CRF), a critical stress

12 Corticotrophin releasing factor (CRF), a stress-related

13 Corticotrophin releasing factor (CRF), enkephalin (ENK),

14 mber of c-Fos immunoreactive neurons express corticotrophin releasing factor (CRF).

15 While corticotrophin releasing factor is the prototypic member

16 c neurons projecting to vasopressinergic and corticotrophin releasing factor neurons in the paraventr

17 ediated through beta-arrestin involvement in Corticotrophin Releasing Factor receptor signalling path

18 However, corticotrophin releasing factor-like-stimulated transpor

19 density of serotonergic, noradrenergic, and corticotrophin releasing factor-positive fibers increase

20 d 50% of cells were depolarised by exogenous corticotrophin releasing factor.

21 ent of neuromodulation by both dynorphin and corticotrophin releasing factor.

22 endogenous interleukin-1beta (IL-1beta) and corticotrophin releasing hormone (CRH) after a periphera

23 ne-related transcript (CART), oxytocin (OX), corticotrophin releasing hormone (CRH) and calcitonin ge

24 icosteroid feedback and its interaction with corticotrophin releasing hormone (CRH) drive.

25 In situ hybridization revealed increased corticotrophin releasing hormone (CRH) mRNA expression i

26 mplicated in anxiety-related behaviours, and corticotrophin releasing hormone (crh) neurons, key regu

27 ower values of paraventricular nucleus (PVN) corticotrophin releasing hormone (CRH), arginine vasopre

28 leus (-24%) and increased levels of mRNA for corticotrophin releasing hormone (CRH, an inhibitor of f

29 ll lines (CHO) transfected with either human corticotrophin releasing hormone 1 (hCRH1) receptors and

30 dexamethasone suppression test followed by a corticotrophin releasing hormone challenge at 10 and 15

31 reduced (P < 0.05) cortisol response to the corticotrophin releasing hormone challenge versus contro

32 5 versus 10-week-old pigs in response to the corticotrophin releasing hormone challenge.

33 ch region extends centromerically beyond the corticotrophin releasing hormone receptor 1 gene (CRHR1)

34 ress gating of BDNF signaling is mediated by corticotrophin-releasing factor (CRF) acting in the NAc.

35 s of addiction also posit a central role for corticotrophin-releasing factor (CRF) and an interaction

36 icular thalamic nucleus (aPVT) which express corticotrophin-releasing factor (CRF) and are preferenti

37 The corticotrophin-releasing factor (CRF) family of neuropep

38 avior are influenced by the highly conserved corticotrophin-releasing factor (CRF) family of peptides

39 gated the existence of somatostatin (SS) and corticotrophin-releasing factor (CRF) in forebrain neuro

40 ollowing dexamethasone (DEX) inhibition, and corticotrophin-releasing factor (CRF) induced activation

41 Corticotrophin-releasing factor (CRF) is expressed in th

42 Endogenous neuropeptide Y (NPY) and corticotrophin-releasing factor (CRF) modulate the respo

43 Corticotrophin-releasing factor (CRF) modulates the infl

44 ion center in the human dorsal pons contains corticotrophin-releasing factor (CRF) neurons, and wheth

45 leptin, insulin, MC-3/4R agonist (MTII), and corticotrophin-releasing factor (CRF) on RSNA in leptin

46 d oxytocin (OT), arginine-vasopressin (AVP), corticotrophin-releasing factor (CRF) or tyrosine hydrox

47 NOS, beta-NGF, proenkephalin B and orphanin, corticotrophin-releasing factor (CRF) R, estrogen R, PAI

48 Natural peptide agonists of corticotrophin-releasing factor (CRF) receptors bind to

49 s modulates GnRH secretion by activating the corticotrophin-releasing factor (CRF) system and sympath

50 the central amygdala (CeA), ethanol acts via corticotrophin-releasing factor (CRF) type 1 receptors t

51 neurons, exhibited different sensitivity to corticotrophin-releasing factor (CRF), a stress hormone

52 lesioned monkeys had decreased levels of CSF corticotrophin-releasing factor (CRF), and both lesioned

53 ts excitatory and inhibitory transmission in corticotrophin-releasing factor (CRF)-expressing dorsal-

54 Here, we demonstrate that corticotrophin-releasing factor (CRF)-expressing neurons

55 nucleus (PVN) contains neurons that release corticotrophin-releasing factor (CRH) and thus provide t

56 n the paraventricular nucleus (PVN), rich in corticotrophin-releasing factor (CRH) and thyrotrophin-r

57 armacological blockade of the stress hormone corticotrophin-releasing factor or of peripheral GC acti

58 es report that application of urocortin I (a corticotrophin-releasing factor receptor-2 agonist) to t

59 Urocortin 3 (Ucn 3) is a corticotrophin-releasing factor related neuropeptide hig

60 A model of the peptide antagonist, cyclic corticotrophin-releasing factor residues 30-41 (cCRF(30-

61 is early aversive effect is mediated via the corticotrophin-releasing factor type 1 receptor (CRF1R,

62 Sympathoactivation to corticotrophin-releasing factor, however, was not affect

63 l structures of this region of receptors for corticotrophin-releasing factor, pituitary adenylate cyc

64 und this core cluster express a reporter for corticotrophin-releasing hormone (Bar(CRH) ).

65 ha-MSH, and this was enhanced in response to corticotrophin-releasing hormone (CRH) acting primarily

66 0.001) and augmenting ACTH responsiveness to corticotrophin-releasing hormone (CRH) action (4-fold, P

67 e input from two hypothalamic secretagogues, corticotrophin-releasing hormone (CRH) and arginine vaso

68 e input from two hypothalamic secretagogues, corticotrophin-releasing hormone (CRH) and arginine vaso

69 Physiological concentrations of corticotrophin-releasing hormone (CRH) and arginine vaso

70 xpression and responsiveness of hypothalamic corticotrophin-releasing hormone (CRH) and arginine vaso

71 orticotrophic hormone (ACTH) by hypothalamic corticotrophin-releasing hormone (CRH) and then stimulat

72 We show that a constant level of corticotrophin-releasing hormone (CRH) can activate a dy

73 The corticotrophin-releasing hormone (CRH) family of peptide

74 one, adrenocorticotrophic hormone (ACTH), or corticotrophin-releasing hormone (CRH) mirroring the glu

75 lar nucleus of the hypothalamus that produce corticotrophin-releasing hormone (CRH) reverse social im

76 However, in the infant rat hypothalamic corticotrophin-releasing hormone (CRH) stress responses

77 The corticotrophin-releasing hormone (CRH) system integrates

78 The principle regulator of the HPA axis is corticotrophin-releasing hormone (CRH), which is made in

79 s (BNST) that otherwise restrain activity of corticotrophin-releasing hormone (CRH)-expressing neuron

80 ium channels that are critical for promoting corticotrophin-releasing hormone (CRH)-induced bursting

81 ion of numerous genes; one such gene encodes corticotrophin-releasing hormone (CRH).

82 Testosterone significantly suppressed the corticotrophin-releasing hormone and arginine vasopressi

83 rexin in the lateral hypothalamus and in the corticotrophin-releasing hormone and oxytocin in the PVH

84 eletion decreased hypothalamic expression of corticotrophin-releasing hormone and oxytocin, neuropept

85 corticoid resistance, resulting in increased corticotrophin-releasing hormone expression, chronic hyp

86 sin, arginine vasopressin V1a receptors, and corticotrophin-releasing hormone mRNA was measured follo

87 Furthermore, these neurons largely express corticotrophin-releasing hormone or thyrotropin-releasin

88 m, identified eight intronic SNPs within the corticotrophin-releasing hormone receptor 1 or CRHR1 loc

89 S (but not unstressed) corticotrophs display corticotrophin-releasing hormone-induced bursting even w

90 After completion of a corticotrophin stimulation test, serum cortisol and 11be